A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.
Zibelman M, MacFarlane AW 4th, Costello K, McGowan T, O'Neill J, Kokate R, Borghaei H, Denlinger CS, Dotan E, Geynisman DM, Jain A, Martin L, Obeid E, Devarajan K, Ruth K, Alpaugh RK, Dulaimi EA, Cukierman E, Einarson M, Campbell KS, Plimack ER.
Zibelman M, et al. Among authors: alpaugh rk.
Nat Commun. 2023 Jul 27;14(1):4513. doi: 10.1038/s41467-023-40028-z.
Nat Commun. 2023.
PMID: 37500647
Free PMC article.
Clinical Trial.